No recent analyst price targets found for GLENMARK.NS.
Latest News for GLENMARK.NS
Glenmark Pharmaceuticals Inc., USA launches Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials
/PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) today announced the launch1 of Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100
Cosmo Welcomes the Launch of Winlevi(R) in Key European Markets by Its Partner Glenmark
Dublin, Ireland--(Newsfile Corp. - June 11, 2026) - Cosmo N.V. (SIX: COPN) (XETRA: C43) ("Cosmo") is pleased to make known that its
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for GLENMARK.NS.
Senate Trading
No Senate trades found for GLENMARK.NS.
U.S. House Trading
No House trades found for GLENMARK.NS.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.